Fluoropyrimidines in Cancer Therapy - Couverture rigide

Couverture rigide

ISBN 10 : 0896039560 ISBN 13 : 9780896039568

Editeur : Humana Press Inc., 2002

Synopsis

Leading cancer researchers update and review the mechanisms of action and the therapeutic selectivity and efficacy of 5-FU with and without leucovorin and its prodrugs in the treatment of colorectal cancer. Among the combination agents considered are UFT/LV, 5-FU/EU, capecitabine (Xeloda), S-1, and a variety of thymidylate synthase inhibitors. The authors discuss the potential advantages and disadvantages of these varied drugs and their mode of administration. Based on historical results with these agents when used alone, they also present a rationale for their results when used in combination with other agents.

Détails de l'édition

• Éditeur: Humana Press Inc.
• Date d'édition: 2002
• Langue: anglais
• ISBN 10: 0896039560
• ISBN 13: 9780896039568
• Reliure: Relié
• Nombre de pages: 338
• Éditeur: Rustum Youcef M.
• Coordonnées du fabricant: Springer Nature Customer Service Center GmbH; ProductSafety@springernature.com; ; Europaplatz 3; Heidelberg; 69115; Allemagne